- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04139746
Pneumatic Retinopexy for Severe Bullous Retinal Detachment
October 23, 2019 updated by: Francesco Semeraro, Università degli Studi di Brescia
Pneumatic Retinopexy Preceded by Drainage of Subretinal Fluid for the Treatment of Severe Bullous Retinal Detachment
To compare the efficacy and safety outcomes of scleral buckling (SB) and drainage-injection-pneumoretinopexy (DIP), a modified pneumatic retinopexy technique, in which, before injecting the gas, the drainage of the subretinal fluid is performed with a simultaneous injection of balanced salt solution (BSS) in the vitreous chamber, for the treatment of severe superior bullous rhegmatogenous retinal detachment (SBRD).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
58
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
BS
-
Brescia, BS, Italy, 25100
- Spedali Civili di Brescia
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 60 years (ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- provision of written informed consent;
- phakic patients aged < 60 years with no or minimal media opacity;
- single or multiple retinal breaks (within 1 clock hour) between 8 to 4 o'clock hours;
- patients' capability to maintain suggested head positioning for 5 days after the procedure.
Exclusion Criteria:
- retinal detachment with poor subretinal fluid (absence of severe SBRD);
- holes, lattice degeneration or traction within the inferior 4 clock hours;
- posterior retinal break, situated behind the equator, not suitable for cryotherapy;
- any sign of PVR or severe glaucoma;
- myopia above 10 diopters.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Scleral Buckling
Scleral Buckling represents the gold standard for retinal detachment in young phakic patients.
|
Limbal 360 degrees peritomy of the conjunctiva was performed and the four recti muscles were isolated with 4 silk threads 4-0.
A width-2 mm silicone encircling band was placed and sutured with 5-0 mersilene on the 4 quadrants of the sclera.
Anterior chamber paracentesis was performed, draining about 0.3 mL of aqueous humour, and a buckle (220, 501, 506, or 516; Mira, Waltham, MA, USA) was sutured over the break.
In all cases, the drainage puncture was executed at a distance of 11 mm from the limbus, in the area of greatest amount of subretinal fluid.
Soon after the drainage puncture, a balanced salt solution (BSS) injection was performed in order to compensate the escape of the subretinal fluid.
|
EXPERIMENTAL: Drainage-Injection-Pneumoretinopexy
Drainage-Injection-Pneumoretinopexy is a modified pneumatic retinopexy technique, in which, before injecting the gas, the drainage of the subretinal fluid is performed with a simultaneous injection of balanced salt solution (BSS) in the vitreous chamber.
|
According to the location of the sub-retinal fluid, a quadrant-flap of conjunctiva was opened.
Indirect ophthalmoscopy evaluation was also used intraoperatively to localize the break and the subretinal fluid drainage site: in this area a vicryl 6-0 thread was passed through the sclera, about 9-10 mm posteriorly from the limbus, to facilitate the surgical maneuvers.
The drainage puncture was performed 11 mm posteriorly from the limbus, having attention not to perform it directly above the site of the retinal break.
In detail, a 2 mm radial sclera incision was created with a 15° disposable knife.
The incision was cautiously deepened down to the choroid, which was finally perforated by a lachrymal dilator having a blunt tip.
Soon after beginning the subretinal fluid drainage, an injection of BSS was performed in the opposite quadrant of the sclera (4 mm from the limbus) in order to allow an optimal spillage of the subretinal fluid and to flatten the retina.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Anatomical reattachment of the retina
Time Frame: 12-month
|
12-month
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Refractive error change
Time Frame: 12-month
|
12-month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
March 1, 2017
Primary Completion (ACTUAL)
March 1, 2019
Study Completion (ACTUAL)
June 30, 2019
Study Registration Dates
First Submitted
October 23, 2019
First Submitted That Met QC Criteria
October 23, 2019
First Posted (ACTUAL)
October 25, 2019
Study Record Updates
Last Update Posted (ACTUAL)
October 25, 2019
Last Update Submitted That Met QC Criteria
October 23, 2019
Last Verified
October 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Vitreo004
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Retina Detachment
-
University of Kansas Medical CenterRecruiting
-
University of AlexandriaCompletedMacular Holes | Retina DetachmentEgypt
-
Seoul National University Bundang HospitalCompletedVitreous Hemorrhage | Cataract | Keratitis | Pterygium | Retina DetachmentKorea, Republic of
-
Sun Yat-sen UniversityUnknownEye Injuries | Retina Detachment | Eye Atrophy | Silicone EmulsionChina
-
The Second People's Hospital of FoshanRecruiting
-
Masaryk Hospital Usti nad LabemCompleted
-
The Second People's Hospital of FoshanNot yet recruiting
-
Shaare Zedek Medical CenterUnknownRetina, Choroid, Sclera
-
New York City Health and Hospitals CorporationCompletedRetinal Degeneration | Retinal Detachment | Retina--DiseasesUnited States
-
Sun Yat-sen UniversityCompletedNormal Eyes | Peripheral RetinaChina
Clinical Trials on Scleral Buckling
-
Singapore National Eye CentreCompleted
-
Shahid Beheshti University of Medical SciencesUnknownPseudophakic Retinal Detachment | Aphakic Retinal DetachmentIran, Islamic Republic of
-
Sun Yat-sen UniversitySuspended
-
Cornea and Laser Eye InstituteRecruitingKeratoconus | Corneal Ectasia | Irregular Astigmatism | Aberration, Corneal Wavefront | Wavefront Aberration, Corneal | Pellucid Marginal Corneal Degeneration | KeratoglobusUnited States
-
Coopervision, Inc.Not yet recruiting
-
ACE Vision Group, Inc.Vision Renu Taiwan CorporationTerminated
-
University of HoustonCompleted
-
Fang WangUnknown
-
London South Bank UniversityCompletedKeratoconus | Irregular Astigmatism | Irregular; Contour of Cornea | Pellucid Marginal Corneal Degeneration | Injury of CorneaUnited Kingdom
-
Rafic Hariri University HospitalUnknown